Screener
Halozyme Therapeutics HALO Book value per share
Book value per share at other companies
Other financials
Where this comes from
Calculated from Halozyme Therapeutics’s reported figures.
Based on the most recent quarter.
The source filing: Halozyme Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001159036-26-000104
FAQ
- What is Halozyme Therapeutics's book value per share?
- Halozyme Therapeutics (HALO) reported book value per share of $1.18 in Q2 2026.
- How has Halozyme Therapeutics's book value per share changed year-over-year?
- Halozyme Therapeutics's book value per share decreased by 55.8% year-over-year, from $2.68 to $1.18.
- What is the long-term trend for Halozyme Therapeutics's book value per share?
- Over 5 years (2020 to 2025), Halozyme Therapeutics's book value per share has grown at a -17.7% compound annual growth rate (CAGR), from $1.04 to $0.39.
- What does book value per share mean?
- Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.
Ask your AI about Halozyme Therapeutics's book value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude